Dr. Cambize Shahrdar, MD

Dr. Shahrdar practices at Wk Orthopedic Clinic in Shreveport, Louisiana.

Dr. Shahrdar's NPI, 1841229978, was assigned on July 1, 2006. Dr. Shahrdar graduated from University of Miami, Lm Miller School of Medicine in 1997. Dr. Shahrdar holds Louisiana license 023868.

Dr. Shahrdar's primary practice is Wk Orthopedic Clinic, at 7925 Youree Dr Ste 200 Suite 200, Shreveport, LA 71105. The practice phone is (318) 212-3610.

Dr. Shahrdar's primary practice is Wk Orthopedic Clinic in Shreveport, Louisiana. Dr. Shahrdar is also affiliated with Willis Knighton North. The medical group on file is Cornerstone Therapy and Balance Center. Dmand AI also links Dr. Shahrdar to 2 more hospitals, 2 home health agencies, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shahrdar practices, 7 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Shahrdar's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Shahrdar is licensed in Louisiana.

Dmand AI lists arthritis, hip replacement, joint pain, knee replacement, lower back pain, neck pain and spine problems, pelvic and hip fracture and removal of damaged skin or skin graft among the conditions Dr. Shahrdar treats.

CMS data shows 10,641 Medicare services from Dr. Shahrdar across 15 procedure codes in 2024, for 684 Medicare patients. Medicare paid $463,721 for them.

CMS counts 684 Medicare patients who saw Dr. Shahrdar in 2024. The largest group is 65 to 74, with 331 patients. 75% of them have arthritis, and 75% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.09, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Shahrdar's median patient age at 71, with 58% women.

In 2024, Dr. Shahrdar wrote 1,390 Medicare Part D claims for 300 patients. 90% of them were for generic drugs. CMS names the drug for 1,305 of them, across 18 drugs with 11 or more claims each, at $13,814 in total drug cost. In 2023, CMS named 1,396 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Shahrdar for performance year 2024, reported through an alternative payment model (APM). Dr. Shahrdar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 67 procedures of hip replacement by Dr. Shahrdar, more than 92% of the clinicians it reports for that procedure.

Lower limb (leg) arthroscopy (minimally invasive joint repair): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Shahrdar in 2021. The most frequent topics are Arthroplasty, Replacement, Hip, Hip Prosthesis and Prosthesis Design. Dr. Shahrdar's most frequent co-authors are Kevin Patrick Smidt, MD, Joseph M. Mirra, MD and Andrew Glen Yun, MD.

CMS Open Payments shows 78 general payments to Dr. Shahrdar from 25 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 77% of the total. Stryker Corporation paid the most, $1,148.

Dmand AI lists 1 award for Dr. Shahrdar, most recently AOA in 1997.

Dr. Shahrdar graduated from University of Miami, Lm Miller School of Medicine in 1997.

Dr. Shahrdar is in network with 16 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.